Simultaneous determination of a novel thrombin inhibitor and its two metabolites in human plasma by liquid chromatography/tandem mass spectrometry
- 3 August 2000
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 23 (2-3) , 607-616
- https://doi.org/10.1016/s0731-7085(00)00353-8
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Determination of a novel thrombin inhibitor in human plasma and urine utilizing liquid chromatography with tandem mass spectrometric and ultraviolet detectionJournal of Chromatography B: Biomedical Sciences and Applications, 2000
- Identification of oxidative degradates of the thrombin inhibitor, 3-(2-phenethylamino)-6-methyl-1-(2-amino-6-methyl-5-methylenecarboxamidomethylpyridinyl)pyrazinone, using liquid chromatography/mass spectrometry and liquid chromatography/tandem mass spectrometryJournal of Pharmaceutical and Biomedical Analysis, 1999
- Small, noncovalent serine protease inhibitorsMedicinal Research Reviews, 1999
- Efficacious, Orally Bioavailable Thrombin Inhibitors Based on 3-Aminopyridinone or 3-Aminopyrazinone Acetamide Peptidomimetic TemplatesJournal of Medicinal Chemistry, 1998
- High-performance liquid chromatographic determination of a new oral thrombin inhibitor in the blood of rats and dogsJournal of Chromatography B: Biomedical Sciences and Applications, 1998
- Thrombin Inhibitor DesignCurrent Medicinal Chemistry, 1998
- Identification and SAR for a selective, nonpeptidyl thrombin inhibitorBioorganic & Medicinal Chemistry Letters, 1998
- Quantitation of an orally available thrombin inhibitor in rat, monkey and human plasma and in human urine by high-performance liquid chromatography and fluorescent post-column derivatization of arginineJournal of Chromatography A, 1997